BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $319,000 | -47.2% | 2,694 | -38.6% | 0.20% | -45.6% |
| Q4 2021 | $604,000 | +17.7% | 4,385 | +18.8% | 0.37% | +10.1% |
| Q3 2021 | $513,000 | +23.6% | 3,691 | -13.6% | 0.34% | +32.2% |
| Q2 2021 | $415,000 | +34.7% | 4,273 | -5.1% | 0.26% | +28.1% |
| Q1 2021 | $308,000 | -3.4% | 4,503 | +21.0% | 0.20% | -8.7% |
| Q4 2020 | $319,000 | +44.3% | 3,721 | +9.4% | 0.22% | +22.5% |
| Q3 2020 | $221,000 | – | 3,401 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |